We then postulated that suppression of Ape1/Chk2 signaling might be one of the defense mechanisms of glioblastoma cells against chronic genomic challenges, which is associated with adoption of alternative ways of HR protein recruitment to damage sites. Here, CHEK2 is linked to glioblastoma.